Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Apr 6, 2017

Total Value: $303M (100.0% shares, 0.0% debt)

Holdings (25)

ACRS Aclaris therapeutics 29.4%

Value $89.12M Shares 3,283,569 Est. Cost $19.11 Unrealized +33.4%

ASND Ascendis Pharma 11.8%

Value $35.76M Shares 1,766,832 Est. Cost $17.51 Unrealized —

CDXS Codexis, Inc. 8.0%

Value $24.36M Shares 5,294,825 Est. Cost $3.85 Unrealized +21.6%

— Nabriva Therapeutics AG 7.9%

Value $23.97M Shares 4,021,559 Est. Cost $8.31 Unrealized —

— Eiger BioPharmaceuticals 6.9%

Value $20.82M Shares 1,787,091 Est. Cost $16.42 Unrealized —

— Aimmune Therapeutics, Inc. 5.1%

Value $15.6M Shares 763,009 Est. Cost $10.82 Unrealized —

— Advanced Accelerator Applications S.A. 4.0%

Value $12.2M Shares 455,798 Est. Cost $35.02 Unrealized —

— Trevena, Inc. 3.3%

Value $10.16M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Foamix Pharmaceuticals Ltd. 3.1%

Value $9.491M Shares 855,000 Est. Cost $9.26 Unrealized —

RGNX Regenxbio Inc. 3.1%

Value $9.328M Shares 502,863 Est. Cost $12.80 Unrealized +49.3%

— Agile Therapeutics, Inc. 2.8%

Value $8.63M Shares 1,513,975 Est. Cost $6.21 Unrealized —

— CoLucid Pharmaceuticals, Inc. 2.7%

Value $8.19M Shares 225,000 Est. Cost $38.15 Unrealized —

— Strongbridge Biopharma plc 2.4%

Value $7.2M Shares 3,000,000 Est. Cost $2.40 Unrealized —

— Capnia, Inc. 2.0%

Value $6.04M Shares 7,456,984 Est. Cost $1.19 Unrealized —

— BioPharmX Corporation 1.6%

Value $4.793M Shares 12,814,286 Est. Cost $0.37 Unrealized —

— Akari Therapeutics Plc 1.2%

Value $3.716M Shares 527,842 Est. Cost $14.00 Unrealized —

— ProNAi Therapeutics, Inc. 1.2%

Value $3.633M Shares 2,438,270 Est. Cost $6.74 Unrealized —

CRSP CRISPR Therapeutics AG 1.0%

Value $3.016M Shares 148,878 Est. Cost $18.69 Unrealized 0.0%

KALV KalVista Pharmaceuticals, Inc. 0.7%

Value $2.123M Shares 300,325 Est. Cost $7.37 Unrealized 0.0%

— Sunesis Pharmaceuticals, Inc. 0.6%

Value $1.81M Shares 500,000 Est. Cost $3.62 Unrealized —

— ReVance Therapeutics, Inc. 0.5%

Value $1.602M Shares 77,373 Est. Cost $24.38 Unrealized —

— Dynavax Technologies Corporation 0.5%

Value $1.421M Shares 359,828 Est. Cost $19.24 Unrealized —

— Ocera Therapeutics, Inc. 0.1%

Value $322K Shares 153,331 Est. Cost $2.94 Unrealized —

— Zosano Pharma Corp 0.0%

Value $77,000 Shares 98,515 Est. Cost $2.30 Unrealized —

— Capnia, Inc. 0.0%

Value $76,000 Shares 943,858 Est. Cost $0.23 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris therapeutics	3,283,569	$89.12M	29.4%	$19.11	+33.4%	Common	00461U105
ASND	Ascendis Pharma	1,766,832	$35.76M	11.8%	$17.51	—	ADR	04351P101
CDXS	Codexis, Inc.	5,294,825	$24.36M	8.0%	$3.85	+21.6%	Common	192005106
—	Nabriva Therapeutics AG	4,021,559	$23.97M	7.9%	$8.31	—	ADR	62957M104
—	Eiger BioPharmaceuticals	1,787,091	$20.82M	6.9%	$16.42	—	Common	28249U105
—	Aimmune Therapeutics, Inc.	763,009	$15.6M	5.1%	$10.82	—	Common	00900T107
—	Advanced Accelerator Applications S.A.	455,798	$12.2M	4.0%	$35.02	—	Common	00790T100
—	Trevena, Inc.	1,728,000	$10.16M	3.3%	$7.67	—	Common	89532E109
—	Foamix Pharmaceuticals Ltd.	855,000	$9.491M	3.1%	$9.26	—	Common	M46135105
RGNX	Regenxbio Inc.	502,863	$9.328M	3.1%	$12.80	+49.3%	Common	75901B107
—	Agile Therapeutics, Inc.	1,513,975	$8.63M	2.8%	$6.21	—	Common	00847L100
—	CoLucid Pharmaceuticals, Inc.	225,000	$8.19M	2.7%	$38.15	—	Common	19716T101
—	Strongbridge Biopharma plc	3,000,000	$7.2M	2.4%	$2.40	—	Ordinary Shares	G85347105
—	Capnia, Inc.	7,456,984	$6.04M	2.0%	$1.19	—	Common	14066L105
—	BioPharmX Corporation	12,814,286	$4.793M	1.6%	$0.37	—	Common	09072X101
—	Akari Therapeutics Plc	527,842	$3.716M	1.2%	$14.00	—	ADR	00972G108
—	ProNAi Therapeutics, Inc.	2,438,270	$3.633M	1.2%	$6.74	—	Common	74346L101
CRSP	CRISPR Therapeutics AG	148,878	$3.016M	1.0%	$18.69	0.0%	Common	H17182108
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2.123M	0.7%	$7.37	0.0%	Common	483497103
—	Sunesis Pharmaceuticals, Inc.	500,000	$1.81M	0.6%	$3.62	—	Common	867328700
—	ReVance Therapeutics, Inc.	77,373	$1.602M	0.5%	$24.38	—	Common	761330109
—	Dynavax Technologies Corporation	359,828	$1.421M	0.5%	$19.24	—	Common	268158201
—	Ocera Therapeutics, Inc.	153,331	$322K	0.1%	$2.94	—	Common	67552A108
—	Zosano Pharma Corp	98,515	$77,000	0.0%	$2.30	—	Common	98979H103
—	Capnia, Inc.	943,858	$76,000	0.0%	$0.23	—	Warrant	14066L113